← Back to Search

Cognitive Training Boosters for Mild Cognitive Impairment (AID-CCT Trial)

N/A
Waitlist Available
Led By Jacqueline E Maye, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

AID-CCT Trial Summary

This trial examines how well cognitive rehabilitation therapies help aging Veterans maintain cognitive and daily functioning, and if booster sessions can further help.

Who is the study for?
This trial is for Veterans aged 55+ who can consent, live independently, speak English, and have completed a prior 'Cognitive Rehabilitation' study. It's not for those with recent substance abuse, significant brain injury (loss of consciousness >30 mins), participation in certain sub-studies, or severe auditory/visual impairments.Check my eligibility
What is being tested?
The study tests the long-term benefits of Compensatory Cognitive Training (CCT) in older Veterans. It compares usual treatments to additional personalized 'booster' sessions aimed at enhancing cognitive function and daily living skills.See study design
What are the potential side effects?
Since this trial involves cognitive training rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during testing or training sessions.

AID-CCT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
"Acceptability of Intervention Measure (AIM)" questionnaire mean score
"Feasibility of Intervention Measure (FIM)" questionnaire mean score
"Intervention Appropriateness Measure (IAM)" questionnaire mean score
Secondary outcome measures
Initial estimate of change in functional capacity performance composite z score
Initial estimate of change in objective cognitive performance composite z score

AID-CCT Trial Design

2Treatment groups
Experimental Treatment
Group I: Treatment as UsualExperimental Treatment1 Intervention
Treatment as Usual
Group II: ME-CCT Booster TrainingExperimental Treatment1 Intervention
3-4 Sessions of ME-CCT Booster Training

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,256 Total Patients Enrolled
Jacqueline E Maye, PhDPrincipal InvestigatorVA San Diego Healthcare System, San Diego, CA

Media Library

ME-CCT Booster Training Clinical Trial Eligibility Overview. Trial Name: NCT05770479 — N/A
Mild Cognitive Impairment Research Study Groups: ME-CCT Booster Training, Treatment as Usual
Mild Cognitive Impairment Clinical Trial 2023: ME-CCT Booster Training Highlights & Side Effects. Trial Name: NCT05770479 — N/A
ME-CCT Booster Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05770479 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation actively recruiting participants?

"As detailed on clinicaltrials.gov, this medical study is not currently recruiting patients. While it was initially posted in July of 2023 and last updated in March of the same year, there are 577 other clinical trials actively seeking candidates at present moment."

Answered by AI

Who else is applying?

What site did they apply to?
VA San Diego Healthcare System, San Diego, CA
What portion of applicants met pre-screening criteria?
Met criteria
~19 spots leftby Jun 2028